-- Aspart (GL-ASP), Lispro (GL-LIS) ? Glargine (GL-GLA)? ?? 1? ?? ???, ?81? ??????? ?????? ??

(??? ? ???? ????? 2021? 7? 2? PRNewswire=????) Gan & Lee Pharmaceuticals Co., Ltd.(?? Gan & Lee, ?? ??: 603087.SH)? ??? 25~29?? ?? ?81? ???????(American Diabetes Association, ADA) ?????? ???? 1? ???? ??? ????. ??? ???? Gan & Lee? ??? ? ?? ?????? ??? ???- insulin aspart (GL-ASP), insulin lispro (GL-LIS) ? insulin glargine (GL-GLA)-? ?? ???, Profil(??)? ?? ?????? ????.

? ?? 1? ?? ?? ?? PK? ?? PD ??? ???. ?? ??? ??, Gan & Lee? ??? ? ?????? ???? ?? ?? ??? ?? ??? ? ???? ?? ???? ????. ??? ??? Gan & Lee? ??? ? ?? ?????? ???? ? ?? ??? ?? ??? ??? ??? ??? ????.[1],[2],[3]

??? ??? ? ???? Gan & Lee? ?????? ?? ?? ?????? ??? ????. 2021?? ???? ??? ? 100??? ?? ??. ??? ??? ???? ??? ????? ???? ??? ????. Gan & Lee ?? ?? ?? Jia Lu? "????? ??? ?? ??? ????? ???, ?????? ???? ?? ???? ? ? ? ? ???? ? ?? ??? ????"?? ????. ? ?? ??? ?? Diabetes(R) ??? ?????? ????. GL-ASP, GL-LIS ? GL-GLA ??? ??? ?? ??? ?? 738-P, 736-P ? 740-P?.

Gan & Lee ??
Gan & Lee? ???? ??? ?? ??? ?? ???? ??? ????. ?? Gan & Lee? ?? ???? glargine ??(Basalin(R)), ???? lispro ??(Prandilin(R)), ???? aspart ??(Rapilin?), ?? protamine zinc lispro ??(25R)(Prandilin(R)25), aspart 30 ??(Rapilin?30), ???? ??? ??? ???(GanleePen?), ??? ? ??(Ganlee Fine?)? ??? ???? ?? ?? ???? ??? ????? ?????.

Gan & Lee? ??? ??? ??? ?? ??? ????, ??? ??, ?? ??, ? ? ?? ??? ???? ??? ????? ???? ? ????? ?????? ??? ??? ????? ??? ?? ??? ?? ???? ??. ?? ??? ??? investorrelations@ganlee.us ? ????.

??:
1.  Leona Plum- M?rschel, et. al. Proposed biosimilar insulin aspart (GL-ASP) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin aspart. June 22, 2021.
2.  Eric Zijlstra, et. al. Proposed biosimilar insulin lispro (GL-LIS) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin lispro. June 22, 2021.
3.  Tim Heise, et. al. Proposed biosimilar insulin glargine (GL-GLA) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin glargine. June 22, 2021.

Gina Antonucci
888-288-5395
investorrelations@ganlee.us